Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: Multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the Impact of antibiotics administered for chemotherapy

K. Sieradzki, T. Leski, J. Dick, L. Borio, A. Tomasz

Research output: Contribution to journalArticle

Abstract

A number of methicillin-resistant Staphylococcus aureus (MRSA) isolates were recovered over a period of several weeks from blood samples and from the heart valve of a patient who underwent extensive vancomycin chemotherapy for persistent S. aureus bacteremia. Consecutive isolates showed gradually decreasing growth rates during in vitro cultivation and increasing vancomycin MICs, from an MIC of 1 μg/ml for the initial isolate to an MIC of 8 μg/ml for the final MRSA isolates, which also became tolerant to vancomycin. Major changes were observed in the oxacillin resistance phenotype of several of the isolates - apparently related to in vivo exposure to imipenem, which was also used during a period of chemotherapy. Both the gradually increasing vancomycin MICs and the changes in oxacillin resistance could be reproduced by appropriate exposure of the initial MRSA isolate to antibiotics in vitro. All isolates had the same pulsed-field gel electrophoresis pattern, spaA type, and multilocus sequence type (MLST), which was identified as a single-locus variant of ST5, the MLST characteristic of previously characterized MRSA isolates with reduced susceptibility to vancomycin in the United States and Japan.

Original languageEnglish (US)
Pages (from-to)1687-1693
Number of pages7
JournalJournal of Clinical Microbiology
Volume41
Issue number4
DOIs
StatePublished - Apr 1 2003

Fingerprint

Vancomycin
Methicillin-Resistant Staphylococcus aureus
Microbial Drug Resistance
Staphylococcus aureus
Anti-Bacterial Agents
Phenotype
Drug Therapy
Oxacillin
Imipenem
Pulsed Field Gel Electrophoresis
Heart Valves
Bacteremia
Japan
Growth
In Vitro Techniques

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

@article{1c4089d4382a420d89ab473753dcc768,
title = "Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: Multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the Impact of antibiotics administered for chemotherapy",
abstract = "A number of methicillin-resistant Staphylococcus aureus (MRSA) isolates were recovered over a period of several weeks from blood samples and from the heart valve of a patient who underwent extensive vancomycin chemotherapy for persistent S. aureus bacteremia. Consecutive isolates showed gradually decreasing growth rates during in vitro cultivation and increasing vancomycin MICs, from an MIC of 1 μg/ml for the initial isolate to an MIC of 8 μg/ml for the final MRSA isolates, which also became tolerant to vancomycin. Major changes were observed in the oxacillin resistance phenotype of several of the isolates - apparently related to in vivo exposure to imipenem, which was also used during a period of chemotherapy. Both the gradually increasing vancomycin MICs and the changes in oxacillin resistance could be reproduced by appropriate exposure of the initial MRSA isolate to antibiotics in vitro. All isolates had the same pulsed-field gel electrophoresis pattern, spaA type, and multilocus sequence type (MLST), which was identified as a single-locus variant of ST5, the MLST characteristic of previously characterized MRSA isolates with reduced susceptibility to vancomycin in the United States and Japan.",
author = "K. Sieradzki and T. Leski and J. Dick and L. Borio and A. Tomasz",
year = "2003",
month = "4",
day = "1",
doi = "10.1128/JCM.41.4.1687-1693.2003",
language = "English (US)",
volume = "41",
pages = "1687--1693",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo

T2 - Multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the Impact of antibiotics administered for chemotherapy

AU - Sieradzki, K.

AU - Leski, T.

AU - Dick, J.

AU - Borio, L.

AU - Tomasz, A.

PY - 2003/4/1

Y1 - 2003/4/1

N2 - A number of methicillin-resistant Staphylococcus aureus (MRSA) isolates were recovered over a period of several weeks from blood samples and from the heart valve of a patient who underwent extensive vancomycin chemotherapy for persistent S. aureus bacteremia. Consecutive isolates showed gradually decreasing growth rates during in vitro cultivation and increasing vancomycin MICs, from an MIC of 1 μg/ml for the initial isolate to an MIC of 8 μg/ml for the final MRSA isolates, which also became tolerant to vancomycin. Major changes were observed in the oxacillin resistance phenotype of several of the isolates - apparently related to in vivo exposure to imipenem, which was also used during a period of chemotherapy. Both the gradually increasing vancomycin MICs and the changes in oxacillin resistance could be reproduced by appropriate exposure of the initial MRSA isolate to antibiotics in vitro. All isolates had the same pulsed-field gel electrophoresis pattern, spaA type, and multilocus sequence type (MLST), which was identified as a single-locus variant of ST5, the MLST characteristic of previously characterized MRSA isolates with reduced susceptibility to vancomycin in the United States and Japan.

AB - A number of methicillin-resistant Staphylococcus aureus (MRSA) isolates were recovered over a period of several weeks from blood samples and from the heart valve of a patient who underwent extensive vancomycin chemotherapy for persistent S. aureus bacteremia. Consecutive isolates showed gradually decreasing growth rates during in vitro cultivation and increasing vancomycin MICs, from an MIC of 1 μg/ml for the initial isolate to an MIC of 8 μg/ml for the final MRSA isolates, which also became tolerant to vancomycin. Major changes were observed in the oxacillin resistance phenotype of several of the isolates - apparently related to in vivo exposure to imipenem, which was also used during a period of chemotherapy. Both the gradually increasing vancomycin MICs and the changes in oxacillin resistance could be reproduced by appropriate exposure of the initial MRSA isolate to antibiotics in vitro. All isolates had the same pulsed-field gel electrophoresis pattern, spaA type, and multilocus sequence type (MLST), which was identified as a single-locus variant of ST5, the MLST characteristic of previously characterized MRSA isolates with reduced susceptibility to vancomycin in the United States and Japan.

UR - http://www.scopus.com/inward/record.url?scp=0037386919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037386919&partnerID=8YFLogxK

U2 - 10.1128/JCM.41.4.1687-1693.2003

DO - 10.1128/JCM.41.4.1687-1693.2003

M3 - Article

C2 - 12682161

AN - SCOPUS:0037386919

VL - 41

SP - 1687

EP - 1693

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 4

ER -